Loading...

Acute myeloid leukemia targets for bispecific antibodies

Despite substantial gains in our understanding of the genomics of acute myelogenous leukemia (AML), patient survival remains unsatisfactory especially among the older age group. T cell-based therapy of lymphoblastic leukemia is rapidly advancing; however, its application in AML is still lagging behi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Cancer J
Main Authors: Hoseini, S S, Cheung, N K
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386336/
https://ncbi.nlm.nih.gov/pubmed/28157217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!